Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 6301 - 6325 of 10551 in total

CP1-1189

CPI-1189 has been used in trials studying the treatment of HIV Infections and AIDS Dementia Complex.
Investigational

Lym-1-I-131

Lym-1-I-131 is a monoclonal antibody labeled with iodine-131 (131I) that preferentially targets malignant lymphocytes.
Investigational
Matched Synonyms: … Monoclonal antibody LYM-1-I-131 ... Murine MAb (Lym-1) and Iodine 131-I radiolabeled murine MAb (Lym-1) to human B-cell lymphoma ... Iodine I 131 Lym-1 Monoclonal Antibody …
Matched Name: … Lym-1-I-131 …
Matched Description: … Lym-1-I-131 is a monoclonal antibody labeled with iodine-131 (131I) that preferentially targets malignant …

VB10.16

VB10.16 is a novel therapeutic antigen-presenting cell-targeting DNA vaccine developed to treat HPV16-positive cancers. It is composed of three parts, one encodes the E6/E7 fusion protein of human papillomavirus (HPV) type 16 (HPV16), a dimerization entity, and the part encoding a protein that specifically binds to antigen-presenting cells (APCs).
Investigational

Thymalfasin

Thymalfasin is a chemically synthesized version of thymosin alpha 1 that is identical to human thymosin alpha 1. Thymosin alpha 1 is an acetylated polypeptide. Thymosin alpha 1 is now approved in 35 developing countries for the treatment of Hepatitis B and C. It is also used to boost the...
Investigational
Matched Description: … alpha 1. ... Thymosin alpha 1 is an acetylated polypeptide. ... Thymalfasin is a chemically synthesized version of thymosin alpha 1 that is identical to human thymosin …

5,7-Dichlorokynurenic acid

Experimental

LY-2584702

LY2584702 has been used in trials studying the treatment of Cancer, Advanced Cancer, Renal Cell Carcinoma, Metastases, Neoplasm, and Neuroendocrine Tumors, among others.
Investigational
Matched Iupac: … 4-{4-[4-fluoro-3-(trifluoromethyl)phenyl]-1-methyl-1H-imidazol-2-yl}-1-{1H-pyrazolo[3,4-d]pyrimidin-4 …
Matched Categories: … Heterocyclic Compounds, 1-Ring …

3-Bromo-7-Nitroindazole

Experimental
Matched Name: … 3-Bromo-7-Nitroindazole …
Matched Iupac: … 3-bromo-7-nitro-1H-indazole …
Matched Categories: … Heterocyclic Compounds, 1-Ring …

Azanidazole

Experimental
Matched Iupac: … 4-[(E)-2-(1-methyl-5-nitro-1H-imidazol-2-yl)ethenyl]pyrimidin-2-amine …
Matched Categories: … Heterocyclic Compounds, 1-Ring …

Pyrrolnitrin

Experimental
Matched Iupac: … 3-chloro-4-(3-chloro-2-nitrophenyl)-1H-pyrrole …
Matched Categories: … Heterocyclic Compounds, 1-Ring …

(1S,2R)-2-[(2,5-difluorophenyl)carbamoyl]cyclopropanecarboxylic acid

Experimental
Matched Iupac: … (1S,2R)-2-[(2,5-difluorophenyl)carbamoyl]cyclopropane-1-carboxylic acid …

N-(2,3,4,5,6-Pentaflouro-Benzyl)-4-Sulfamoyl-Benzamide

Experimental

Apomorphine palmitate

Investigational
Matched Iupac: … -hexaen-3-yl hexadecanoate ... (9R)-4-(hexadecanoyloxy)-10-methyl-10-azatetracyclo[7.7.1.0^{2,7}.0^{13,17}]heptadeca-1(17),2(7),3,5,13,15 …

7-Nitroindazole-2-Carboxamidine

Experimental

(R)-4-Nitrostyrene oxide

Experimental

2-[1-METHYLHEXYL]-4,6-DINITROPHENOL

Experimental
Matched Name: … 2-[1-METHYLHEXYL]-4,6-DINITROPHENOL …

Diglyme

Experimental
Matched Synonyms: … 2,2'-oxybis(1-methoxyethane) ... 2,2'-oxybis[1-(methyloxy)ethane] …
Matched Iupac: … 1-methoxy-2-(2-methoxyethoxy)ethane …

BMS-564929

BMS-564929 is an investigational therapeutic agent built to be a selective androgen receptor modulator (SARM). So far, it has been developed by Bristol-Myers Squibb for the symptomatic treatment of andropause.
Experimental
Matched Iupac: … 4-[(7R,7aS)-7-hydroxy-1,3-dioxo-hexahydro-1H-pyrrolo[1,2-c]imidazol-2-yl]-2-chloro-3-methylbenzonitrile …
Matched Categories: … Heterocyclic Compounds, 1-Ring …

CH-5132799

CH5132799 has been used in trials studying the treatment of Solid Tumors.
Investigational
Matched Iupac: … 5-[7-methanesulfonyl-2-(morpholin-4-yl)-5H,6H,7H-pyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine …
Matched Categories: … Heterocyclic Compounds, 1-Ring ... Class I Phosphatidylinositol 3-Kinases, antagonists & inhibitors …

SLN500

SLN500 is a synthetic double-strand small interfering ribonucleic acid (siRNA) oligonucleotide drug directed against C3 messenger RNA
Investigational

LL-37

LL-37 is a human cathelicidin that inhibits viral replication and while also playing a role in host defense against infection.
Investigational

Nemvaleukin alfa

Investigational
Matched Synonyms: … protein with 4-74-interleukin 2 (human) fusion protein with peptide linker (gsgggs) fusion protein with 1- ... protein with 4-74-interleukin 2 (human) fusion protein with peptide linker (GSGGGS) fusion protein with 1- ... human interleukin 2 fragment (1-59), variant (Cys125>Ser51), fused via peptidyl linker (60GG61) to human …

Enoxolone

Enoxolone (glycyrrhetic acid) has been investigated for the basic science of Apparent Mineralocorticoid Excess (AME).
Investigational
Matched Salts cas: … 2508-76-1 ... 85985-61-1 …
Matched Mixtures name: … ANZİBEL 5 MG/4 MG/3 MG EKİNEZYALI PASTİL, 20 ADET ... ANZİBEL 5 MG/4 MG/3 MG MEYANBALLI PASTİL, 20 ADET ... ANZİBEL 5 MG/4 MG/3 MG ZENCEFİLLİ PASTİL, 20 ADET …

N-Benzylformamide

Experimental

Chlorproguanil

Chlorproguanil has been used in trials studying the treatment of MALARIA. It is a dichloro-derivative of chloroguanide.
Investigational
Matched Iupac: … 1-[N'-(3,4-dichlorophenyl)carbamimidamido]-N-(propan-2-yl)methanimidamide …

SynOV1.1

SynOV1.1 is an investigational cancer immunotherapy developed by SyngenTech. It is a recombinant oncolytic adenovirus, controlled by synthetic gene circuit, encoding the human immunostimulating factor cytokine granulocyte-macrophage colony-stimulating factor (GM-CSF). SynOV1.1 is under investigation in clinical trial NCT04612504 (Synov1.1 Intratumoral Injection Study).
Investigational
Displaying drugs 6301 - 6325 of 10551 in total